Table of Contents
| << Previous Issue | Sep 2011 (Vol: 2011, Issue: 9) | Next Issue >> |
- Section: Licensing
-
Roche Licenses Alzheimer’s Disease Drug Candidate from Evotec in Potential US$830 M Deal
- Section: Mergers & Acquisitions
-
Par Pharmaceutical to Acquire Second Generics Company of 2011
-
Baxter Expands its Medication Delivery Business with Baxa Acquisition
-
Sanofi’s Aventis Pharma Subsidiary to Acquire Nutraceuticals Business of India’s Universal Medicare
-
Valeant Outbids Paladin Labs with US$78 M Offer to Acquire Afexa Life Sciences
-
PerkinElmer Agrees to Acquire Caliper Life Sciences for US$600 M
-
Jazz Pharmaceuticals to Diversify its Portfolio with Azur Pharma Merger
- Section: Research & Development
-
Merck Serono and F-star Form Next-Generation Antibody Development Pact
-
Merck & Co. Forms Bispecific Antibody Collaboration with Zymeworks
-
Biogen Idec and Novo Nordisk Join Adimab’s List of Antibody Discovery Partners
-
Teva Invests in Cocrystal Discovery to Strengthen Speciality Pipeline with Antiviral Therapies
RSS